Volpara Health Technologies Ltd (ASX: VHT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Volpara Health Technologies Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $288.71 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 254.83 million
Earnings per share -0.036
Dividend per share N/A
Year To Date Return 2.71%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Volpara Health Technologies Ltd (ASX: VHT)
    Latest News

    appen share price
    Share Market News

    3 ASX shares using AI to help supercharge profits

    Artificial intelligence could be the next trend to boost businesses.

    Read more »

    A woman peers through a bunch of recycled clothes on hangers and looks amazed.
    Cheap Shares

    How I'm aiming to find under-the-radar cheap ASX shares right now

    The ASX has thrown up a number of intriguing opportunities.

    Read more »

    A cool young man walking in a laneway holding a takeaway coffee in one hand and his phone in the other reacts with surprise as he reads the latest news on his mobile phone
    Opinions

    Top ASX shares under $3 to buy in July 2023

    Here are some well-priced ASX shares to charge up your portfolio for FY24.

    Read more »

    A girl is handed an oversized ice cream cone with lots of different flavours.
    Growth Shares

    3 ASX growth shares I think are monsters in the making

    I’m expecting huge things from these 3 stocks.

    Read more »

    Woman preparing to have her breast screened with the support of a young female doctor.
    Healthcare Shares

    Here's why the Volpara Health share price is leaping 7% today

    This company is beginning to move towards being cash flow positive.

    Read more »

    A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
    Growth Shares

    I rate these strong ASX growth shares as buys for FY24 and beyond

    Here’s why these two small businesses could grow into much bigger stocks.

    Read more »

    Happy man holding Australian dollar notes, representing dividends.
    Investing Strategies

    Got $20k in savings? Here's how I'd aim to turn it into $100k with ASX shares

    If I were looking to 'five times' my money, here’s how I’d try to do it.

    Read more »

    a woman stares ahead with a serious expression on her face while half of her face is covered by computer coding, indicative of artificial intelligence and machine learning technology.
    Technology Shares

    Should I be buying ASX artificial intelligence shares right now?

    'AI' might go down as the most-used term of 2023. So is it time investors wake up to its potential?

    Read more »

    A woman holds her hand out under a graphic hologram image of a human brain with brightly lit segments and section points.
    Technology Shares

    2 under-the-radar ASX tech shares that could benefit from the AI boom

    Here are a couple of ideas for investors looking for AI options.

    Read more »

    A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.
    Share Market News

    Are we in the middle of a once-in-a-lifetime chance to buy cheap ASX shares?

    The ASX has been an international laggard in 2023.

    Read more »

    A man in a business suit and a tie leans forward with an excited, wide-mouthed expression and holds up one finger to the camera as if indicating the number one.
    Opinions

    This is my #1 ASX growth share to buy right now

    I’m backing this ASX healthcare share as an exciting opportunity.

    Read more »

    two magicians wearing dinner suits with bow ties wave their magic wands over a levitating bag with a dollars sign on it.
    How to invest

    Could ASX shares turn a $10,000 investment into $2,000,000?

    Compounding is a very powerful financial force which can help grow wealth.

    Read more »

    Frequently Asked Questions

    No, the ASX healthcare share has not yet paid any dividends.

    Volpara listed on 27 April 2016.

    VHT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Volpara Health Technologies Ltd

    Volpara Health Technologies Ltd (ASX: VHT) is a small but growing research, development, and manufacturing company that provides breast screening technology and risk analysis for patients and medical professionals.

    Volpara’s artificial intelligence-powered software for early detection of breast cancer is used by more than 2,000 facilities and more than 5,600 mammography technologists, impacting nearly 15 million patients globally. Volpara is based in Wellington, New Zealand, and also has a US office in Seattle.

    VHT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    28 Mar 2024 $1.14 $0.00 0.00% 539,358 $1.13 $1.14 $1.13
    27 Mar 2024 $1.14 $0.00 0.00% 127,606 $1.13 $1.14 $1.13
    26 Mar 2024 $1.14 $0.00 0.00% 64,750 $1.13 $1.14 $1.13
    25 Mar 2024 $1.14 $0.01 0.88% 664,855 $1.13 $1.14 $1.13
    22 Mar 2024 $1.13 $-0.01 -0.88% 1,412,689 $1.13 $1.13 $1.13
    21 Mar 2024 $1.14 $0.01 0.89% 1,093,007 $1.13 $1.14 $1.13
    20 Mar 2024 $1.13 $0.00 0.00% 84,031 $1.13 $1.14 $1.13
    19 Mar 2024 $1.13 $0.00 0.00% 2,861,710 $1.13 $1.13 $1.13
    18 Mar 2024 $1.13 $0.00 0.00% 531,121 $1.13 $1.13 $1.13
    15 Mar 2024 $1.13 $0.00 0.00% 385,743 $1.13 $1.14 $1.13
    14 Mar 2024 $1.13 $0.00 0.00% 2,037,806 $1.13 $1.14 $1.13
    13 Mar 2024 $1.13 $0.00 0.00% 558,056 $1.13 $1.13 $1.13
    12 Mar 2024 $1.13 $0.00 0.00% 310,599 $1.12 $1.13 $1.12
    11 Mar 2024 $1.12 $0.00 0.00% 503,145 $1.12 $1.13 $1.12
    08 Mar 2024 $1.12 $0.00 0.00% 270,682 $1.13 $1.13 $1.12
    07 Mar 2024 $1.12 $-0.01 -0.88% 137,991 $1.13 $1.13 $1.12
    06 Mar 2024 $1.13 $0.01 0.89% 153,301 $1.12 $1.13 $1.12
    05 Mar 2024 $1.12 $0.00 0.00% 47,579 $1.12 $1.13 $1.12
    04 Mar 2024 $1.12 $0.00 0.00% 182,554 $1.12 $1.13 $1.12
    01 Mar 2024 $1.13 $0.00 0.00% 847,151 $1.13 $1.13 $1.12
    29 Feb 2024 $1.12 $0.00 0.00% 32,406 $1.12 $1.12 $1.12
    28 Feb 2024 $1.12 $0.00 0.00% 1,552,964 $1.12 $1.13 $1.12
    27 Feb 2024 $1.12 $0.00 0.00% 285,243 $1.12 $1.13 $1.12

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    17 Aug 2023 Mark Bouw Issued 450,000 $585,000
    Issue of options.
    02 Jun 2023 Teri Thomas Sell 3,577 $2,546
    On-market trade.
    01 Jun 2023 Teri Thomas Exercise 75,280 $57,213
    Conversion of securities. 150,561 RSUs, As per announcement on 02-06-2023
    01 Jun 2023 Teri Thomas Buy 75,280 $57,213
    Conversion of securities. As per announcement on 02-06-2023

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Roger Allen Non-Executive Director Jun 2010
    Roger was Volpara s first major investor, joined the Board
    prior to FDA approval in June 2010, and was Chair from
    October 2015 to March 2019.
    Roger is a well-known entrepreneur, venture capitalist (VC),
    and social impact investor and philanthropist whose global
    career has spanned over 50 years. He helped pioneer the
    Australian technology industry through the Computer
    Power Group, one of the first Australian-founded tech
    companies to scale globally and subsequently IPO in 1987,
    turning over approx. $1B in today s currency. Following
    the companys acquisition in 1995, he cofounded Allen &
    Buckeridge Pty Ltd, one of the first early-stage VC firms.
    Mr John Dimitrious Pavlidis Non-Executive Director Feb 2015
    John Pavlidis joined the VHT board in February
    2015 and has more than 30 years of experience
    as a senior healthcare executive, CEO, or
    company director in the areas of womens health,
    diagnostic imaging, image analysis and artificial
    intelligence, and cardiovascular therapies.
    Mr Paul Reid Non-Executive DirectorNon-Executive Chairman Mar 2018
    Paul joined the Board in March 2018 and brings extensive
    commercial experience gained across a range of
    technology/Software as a Service businesses.
    He was the founding CEO and Chairman of Figured
    Limited, a fintech SaaS company that provides
    management accounting software to farmers in the
    United States, the United Kingdom ,
    Australia, and New Zealand . Figured was the
    NZ Hi-Tech Startup Company of the Year in 2016 and
    has grown at an incredible pace, funded by private,
    corporate and venture capital (VC) investors.
    Ms Karin Lindgren Non-Executive Director Jan 2020
    Karin joined the Board in 2020. She brings over 35 years
    experience in health information technology as a senior
    technology executive and law firm partner. As one of
    the earliest healthcare technology lawyers in the USA,
    Karin has an in-depth knowledge of data governance,
    data privacy, SaaS, and US healthcare, and has extensive
    professional networks across the IT landscape
    Ms Ann Custin Non-Executive Director Sep 2021
    network of industry contacts from an extensive
    career in healthcare across Europe, the Americas,
    and Asia. Her most recent executive role was with
    Siemens Healthineers, where she served as both CFO
    and board director of Siemens Medical Solutions.
    Prior to this role, Ann served as Chief Operating
    and Financial Officer of Scientx and President &
    CEO of USA Draeger Medical Systems, Inc.
    Ms Teri Thomas Chief Executive OfficerManaging Director Apr 2022
    Teri joined the Board in October 2022. She has a
    long history of executive management in healthcare
    IT ranging from strategy and operations to running
    global sales and marketing teams. This includes a
    20-year career at Epic, a global leader in electronic
    health record (EHR) systems and other software
    solutions used by hospitals and healthcare
    organisations in the United States and internationally
    Mr Mark Bouw Non-Executive Director Jan 2023
    Mr Bouw is a experienced senior healthcare CEO .He is a visiting consultant at Stanford University Graduate Business School Seed Program in the United States and is a visiting mentor for Stanfords Ignite program.
    Mr Craig Hadfield Chief Financial OfficerJoint Company Secretary Mar 2017
    -
    Mr Fred Struve General CounselJoint Company Secretary Oct 2022
    -
    Craig Hadfield Chief Financial OfficerJoint Company Secretary
    -
    Fred Struve General CounselJoint Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    No Top 20 27,534,688 10.84%
    Patagorang Pty Ltd 18,467,848 7.27%
    Ralph Highnam And Kyc Trustees 106 Limited <Highnam Share A/C> 16,213,561 6.38%
    Citicorp Nominees Pty Limited 11,830,450 4.66%
    HSBC Custody Nominees (Australia) Limited 8,187,911 3.22%
    Custodial Services Limited <Beneficiaries Holding A/C> 8,154,911 3.21%
    Bnp Paribas Noms (Nz) Ltd <Drp> 7,061,556 2.78%
    Prof Sir Michael Brady 6,619,075 2.61%
    Mr Marcus Sarner 5,980,404 2.35%
    National Nominees Limited 4,728,818 1.86%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient 4,420,193 1.74%
    Sir Martin Francis Wood 3,004,655 1.18%
    Lady Kathleen Audrey Wood 3,004,654 1.18%
    BNP Paribas Noms Pty Ltd <Drp> 2,527,511 0.99%
    Prof Martin Yaffe 1,966,483 0.77%
    Mr John Anthony Dell 1,928,864 0.76%
    BNP Paribas Nominees Pty Ltd HUB24 Custodial Serv Limited 1,917,409 0.75%
    Prof Nico Karssemeijer 1,806,806 0.71%
    Melbourne Securities Corporation Limited <Horizon 3 Biotech Fund A/C> 1,519,964 0.60%
    RX HOUSE TRUST PTY LTD 880,758 0.35%

    Profile

    since

    Note